Recent BioUtah News & Events

On January 7, join the three-hour event featuring topics such as company COVID responses, the pandemic’s impact on the real estate industry, innovations in life sciences, and more! Learn more and register here.

Leaders of both parties inched closer on Thursday to agreement on a COVID-19 stimulus package. The package would include more funding for PPP loans, allow a second loan draw for hard-hit small businesses and streamline forgiveness for loans of $150,000 or less. In addition, the measure is expected to include some level of direct payments […]

12/10/2020 – IONIQ Sciences has been designated as 2020’s ‘Most Innovative Cancer Detection and Diagnostics Technology Firm’ by CV Magazine. Our goal to modernize cancer testing has taken us to exciting heights this year. We resolutely believe in our potential to introduce a ‘breakthrough’ Multi-Cancer Screen that will non-invasively detect the presence of malignancy in its earliest stages utilizing our Electrical Impedance Analytics […]

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently presented new data from the Phase 2 Zella 201 study evaluating the investigational agent alvocidib, a potent CDK9 inhibitor, in patients with MCL-1 dependent acute myeloid leukemia (AML). These results were presented at the 62nd American Society of Hematology Annual Meeting, which was held virtually December 5-8, […]

Governor Herbert yesterday announced that teachers would move up to the front of the line for the COVID-19 vaccine. In addition to teachers, the first phase of vaccinations in Utah will focus on healthcare workers, as well as residents and staff of long-term care facilities. Last week, BioUtah sent a letter to the Utah Department […]

The Trump administration recently announced an interim final rule to implement the Most Favored Nation drug pricing model, which would tie prices of certain Medicare Part B drugs to the lowest prices paid in Organisation for Economic Cooperation and Development (OECD) countries. In response, drug industry trade groups have filed two lawsuits against the administration on December […]

Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today announced the first patient has been dosed in a Phase 1b/2 study evaluating the oral investigational agent, dubermatinib (TP-0903), an AXL kinase inhibitor, in combination with decitabine, in patients 60 years or older with newly diagnosed acute myeloid leukemia (AML) who have TP53 […]

Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today announced the first patient has been dosed in the Phase 2 expansion portion of the study evaluating DSP-7888, an investigational immunotherapeutic cancer vaccine that targets Wilms Tumor 1 (WT1), in combination with checkpoint inhibitor pembrolizumab, in patients with platinum-resistant ovarian cancer (PROC). The […]

Register here.

The fifteenth annual BIO-Europe Spring® premier springtime partnering conference will be held March 22-25 in a fully digital format. It will include on-demand early access to the company pitches, program sessions, and sponsor and showcase company content up to five weeks prior to the live event for the best possible networking and meeting decisions once […]

The BIO Asia International Conference in Tokyo brings together the global biotechnology and pharmaceutical industry to explore licensing collaborations and investor engagement in the current Asia-Pacific business and policy environments. Gain insights into the changes, challenges, and opportunities key opinion and policy leaders foresee for the Japanese biotech market and throughout the region.  Companies with […]

For more than 20 years, the BIO CEO & Investor Conference has fueled biotech industry networking with premier investor and banking communities, focused on established and emerging publicly traded and select private biotech companies. The virtual 2021 event, taking place February 16-18, will showcase the Biotechnology Innovation Organization’s (BIO) perspective on the new U.S. Congressional […]

Maximize Your Time During JPM Week with BIO One-on-One Partnering™ BIO One-on-One Partnering is your virtual partnering and business development companion, with integrated video conferencing and more biotechnology-specific search filters & therapeutic categories than any other major platform to help you target potential partners faster than ever.  Learn more about BIO One-on-One Partnering → Participating in BIO […]

December 3, 2020 Mr. Rich Lakin, MSPH, MPA Immunizations Director Utah Department of Health Bureau of Epidemiology PO Box 142102 Salt Lake City, UT 84114-2102 Dear Director Lakin: As a state plan for the allocation of COVID-19 vaccinations is formulated, BioUtah urges you to include employees of Utah’s life sciences companies among priority recipients of […]

A letter written by BIO’s president and CEO Michelle McMurry-Heath dated December 4, 2020.  Dear BIO Members, Today BIO, together with California Life Sciences Association (CLSA) and BIOCOM California, will announce our plan to challenge the Department of Health and Human Services’ (HHS) attempt, during the final days of the Trump Administration, to implement for […]

SALT LAKE CITY (Dec. 2, 2020) – Gov.-elect Spencer Cox and Lt. Gov.-elect Deidre Henderson have announced another round of key appointments who will join their administration after they take the Oath of Office in January. Brittney Cummins, who has served as a member of the Utah State Board of Education since 2014, will join […]

In a virtual December 3 ceremony, the American Life Sciences Innovation Council (ALSIC), BioUtah and several state and local-based patient organizations, presented Rep. Ben McAdams (UT-4) with the 2020 Champion of Health Care Innovation Award. The award recognizes McAdams for his work in Congress to protect and nurture the important policies that position Utah and […]

With the CDC’s prioritization recommendations as guidance, states will make the final decisions about vaccine allocation in their states. The Utah Department of Health, Department of Public Safety along with Governor Herbert and Governor-Elect Cox are actively working to refine the state’s initial COVID-19 Vaccination Plan. An anticipated vaccination timeline can be viewed here. BioUtah […]

With the first shipments of the Pfizer/BioNTech vaccine scheduled to arrive in a matter of weeks and Moderna doses soon after, a big question looms: who gets them first? Independent health policy experts on the vaccine advisory committee to the Centers for Disease Control and Prevention (CDC) met this week to make a recommendation. The CDC Advisory Committee on […]

These days we can all use uplifting news, so please check out this short story about how BraveHeart technology is harnessing AI to bridge India’s healthcare divide. iKures, an Indian healthcare company, is equipping community workers in remote areas of the country with BraveHeart portable devices to measure blood pressure, hemoglobin levels, or heart rates […]

Utah continues to support the business community during the COVID-19 pandemic with its COVID-19 Small Business Quarantined Employee Grant program. If an employee needs to quarantine or isolate due to a COVID-19 exposure or positive test, employers can continue paying them and be reimbursed with this grant program. Utah created this program to reimburse small […]

Co-Diagnostics announced November 25 that CoSara Diagnostics Pvt Ltd (“CoSara,” or the “JV”), its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization (“CDSCO”) in India to manufacture and sell its Saragene™ COVID-19 2-gene multiplex RT-PCR test. Dwight Egan, CEO of Co-Diagnostics, said “tests built on […]

I frequently remind my team and legislators that economic development is a journey, not a destination. And what a journey it has been for me the last six-and-a-half years! When Gov. Gary Herbert asked me to take this job in 2014, Utah was still feeling the residual effects of the Great Recession. However, our economy […]

The three companies have partnered together to bring wearable BraveHeart patches to at-risk patient’s in India’s remote “last mile.” Read the full article from CNN here.